99 related articles for article (PubMed ID: 3761321)
41. Antibacterial activity of the metabolites of ciprofloxacin and its significance in the bioassay.
Zeiler HJ; Petersen U; Gau W; Ploschke HJ
Arzneimittelforschung; 1987 Feb; 37(2):131-4. PubMed ID: 3555512
[TBL] [Abstract][Full Text] [Related]
42. The comparative activity of norfloxacin with other antimicrobial agents against Gram-positive and Gram-negative bacteria.
Corrado ML; Cherubin CE; Shulman M
J Antimicrob Chemother; 1983 Apr; 11(4):369-76. PubMed ID: 6222023
[TBL] [Abstract][Full Text] [Related]
43. The comparative in-vitro activity of norfloxacin, ciprofloxacin, enoxacin and nalidixic acid against 423 strains of gram-negative rods and staphylococci isolated from infected hospitalised patients.
Guimaraes MA; Noone P
J Antimicrob Chemother; 1986 Jan; 17(1):63-7. PubMed ID: 2936708
[TBL] [Abstract][Full Text] [Related]
44. Synthesis, Characterization and Antimicrobial Evaluation of Lipid Based Norfloxacin Prodrug.
Sharma PC; Piplani M; Rajak H
Curr Drug Deliv; 2018 Feb; 15(2):219-226. PubMed ID: 27758690
[TBL] [Abstract][Full Text] [Related]
45. The sensitivity of gram-negative and gram-positive bacteria to ofloxacin.
Speciale A; Stefani S; Caccamo F; Nicolosi VM; Nicoletti G
Chemioterapia; 1987 Feb; 6(1):17-22. PubMed ID: 3470153
[TBL] [Abstract][Full Text] [Related]
46. In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.
Kern W; Gulden H; Vanek E; Kurrle E
Chemotherapy; 1988; 34(2):117-26. PubMed ID: 3164670
[TBL] [Abstract][Full Text] [Related]
47. In vitro effect of pH and glucose concentration on the antibacterial activity of norfloxacin in urine.
Fromtling RA; Abruzzo GK; Gadebusch HH
Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):737-41. PubMed ID: 6241649
[TBL] [Abstract][Full Text] [Related]
48. Review of Properties and Analytical Methods for the Determination of Norfloxacin.
Chierentin L; Salgado HR
Crit Rev Anal Chem; 2016; 46(1):22-39. PubMed ID: 26398574
[TBL] [Abstract][Full Text] [Related]
49. Design, synthesis and in vitro antibacterial/antifungal evaluation of novel 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7(1-piperazinyl)quinoline-3-carboxylic acid derivatives.
Yu Z; Shi G; Sun Q; Jin H; Teng Y; Tao K; Zhou G; Liu W; Wen F; Hou T
Eur J Med Chem; 2009 Nov; 44(11):4726-33. PubMed ID: 19560843
[TBL] [Abstract][Full Text] [Related]
50. Enhancement of antibacterial activity of norfloxacin and ofloxacin in vitro by serum and experimental pleural exudates.
Miglioli PA; Sartore P; Gianfranceschi L; Lanzafame P; Berti T
J Chemother; 1989 Jul; 1(4 Suppl):140-1. PubMed ID: 16312342
[No Abstract] [Full Text] [Related]
51. [Laboratory and clinical studies on norfloxacin in pediatrics].
Sato Y; Iwata S; Akita H; Sunakawa K
Jpn J Antibiot; 1990 May; 43(5):826-36. PubMed ID: 2391753
[TBL] [Abstract][Full Text] [Related]
52. The comparative in vitro activity of ofloxacin (RU 43 280) and other quinolone derivatives against 722 bacteria of clinical interest.
Santos Ferreira M; Vital J
Chemioterapia; 1987 Jun; 6(2 Suppl):145-7. PubMed ID: 2908239
[No Abstract] [Full Text] [Related]
53. Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin.
Hohl P; Felber AM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():71-80. PubMed ID: 3144552
[TBL] [Abstract][Full Text] [Related]
54. Metalloantibiotics: synthesis, characterization and antimicrobial evaluation of bismuth-fluoroquinolone complexes against Helicobacter pylori.
Shaikh AR; Giridhar R; Megraud F; Yadav MR
Acta Pharm; 2009 Sep; 59(3):259-71. PubMed ID: 19819823
[TBL] [Abstract][Full Text] [Related]
55. Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents.
Zheng QZ; Cheng K; Zhang XM; Liu K; Jiao QC; Zhu HL
Eur J Med Chem; 2010 Jul; 45(7):3207-12. PubMed ID: 20381216
[TBL] [Abstract][Full Text] [Related]
56. Antibacterial evaluation of a collection of norfloxacin and ciprofloxacin derivatives against multiresistant bacteria.
Vila J; Sánchez-Céspedes J; Sierra JM; Piqueras M; Nicolás E; Freixas J; Giralt E
Int J Antimicrob Agents; 2006 Jul; 28(1):19-24. PubMed ID: 16781123
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, antimicrobial evaluation and QSAR studies of 2-chlorobenzoic acid derivatives.
Mehta S; Kumar P; Marwaha RK; Narasimhan B
Drug Res (Stuttg); 2014 Apr; 64(4):208-13. PubMed ID: 24258706
[TBL] [Abstract][Full Text] [Related]
58. [In vitro activity of norfloxacin against gram-positive and gram-negative organisms from recent clinical isolates].
Mancini C; Brenciaglia MI; Ghezzi MC; Giordano A; Nazzari C; Cipriani P
Boll Ist Sieroter Milan; 1985; 64(4):289-93. PubMed ID: 3935135
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and in-vitro antibacterial activity of some novel N-nicotinoyl-1-ethyl-6-fluoro-1,4-dihydro-7-piperazin-1-yl-4-oxoquinoline-3-carboxylates.
Sharma PC; Jain S
Acta Pol Pharm; 2008; 65(5):551-6. PubMed ID: 19051601
[TBL] [Abstract][Full Text] [Related]
60. Antibacterial effect of some essential oils administered alone or in combination with Norfloxacin.
Rosato A; Vitali C; De Laurentis N; Armenise D; Antonietta Milillo M
Phytomedicine; 2007 Nov; 14(11):727-32. PubMed ID: 17303397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
